Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 454

1.

Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

Iloeje UH, Yang HI, Chen CJ.

Liver Int. 2012 Oct;32(9):1333-41. doi: 10.1111/j.1478-3231.2012.02805.x. Epub 2012 Apr 17. Review.

PMID:
22510145
2.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
3.

Risk stratification for hepatitis B virus related hepatocellular carcinoma.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2013 Jan;28(1):10-7. doi: 10.1111/jgh.12010.

PMID:
23094699
4.

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ; REVEAL-HBV Study Group.

J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243. Epub 2008 Aug 11.

5.

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ.

J Clin Oncol. 2010 May 10;28(14):2437-44. doi: 10.1200/JCO.2009.27.4456. Epub 2010 Apr 5.

PMID:
20368541
6.

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.

Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS.

J Infect Dis. 2006 May 1;193(9):1258-65. Epub 2006 Apr 4.

PMID:
16586363
7.

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL.

Gastroenterology. 2008 Oct;135(4):1192-9. doi: 10.1053/j.gastro.2008.07.008. Epub 2008 Jul 16.

PMID:
18722377
8.

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G.

J Natl Cancer Inst. 2009 Aug 5;101(15):1066-82. doi: 10.1093/jnci/djp180. Epub 2009 Jul 2.

9.

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

Lin CL, Kao JH.

J Biomed Sci. 2008 Mar;15(2):137-45. Epub 2007 Dec 5. Review.

PMID:
18058038
10.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
11.

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.

Liu CJ, Kao JH.

Semin Liver Dis. 2013 May;33(2):97-102. doi: 10.1055/s-0033-1345716. Epub 2013 Jun 8. Review.

PMID:
23749665
12.

Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.

Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH.

Liver Int. 2005 Jun;25(3):564-70.

PMID:
15910494
13.

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

Tseng TC, Liu CJ, Chen PJ, Lai MY, Lin CL, Kao JH, Chen DS.

Liver Int. 2007 Sep;27(7):983-8.

PMID:
17696938
14.

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group.

Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.

PMID:
20114048
15.

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Hepatology. 2012 Jan;55(1):68-76. doi: 10.1002/hep.24615.

PMID:
21858846
16.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
17.

Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.

Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL–HBV) Study Group.

Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. doi: 10.1053/j.gastro.2011.06.036. Epub 2011 Jun 22.

PMID:
21703214
18.

The clinical implications of hepatitis B virus genotype: Recent advances.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30. doi: 10.1111/j.1440-1746.2010.06541.x. Review.

PMID:
21199523
19.

Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.

Nien HC, Sheu JC, Kao JH, Chou HC, Su CW, Chen CH.

J Med Virol. 2011 Aug;83(8):1326-31. doi: 10.1002/jmv.22135.

PMID:
21678436
20.

Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.

Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.

J Gastroenterol Hepatol. 2008 Mar;23(3):474-81. doi: 10.1111/j.1440-1746.2008.05321.x.

PMID:
18318825

Supplemental Content

Support Center